# Click chemistry-based drug delivery systems for targeted cancer therapy

**Authors:** Yonghui Liu, Wei Zhang, Yanan Wu, Dong Wan, Jie Pan

PMC · DOI: 10.1016/j.mtbio.2026.102912 · Materials Today Bio · 2026-02-12

## TL;DR

This review discusses how click chemistry can improve drug delivery systems for cancer treatment by enabling precise targeting and controlled drug release.

## Contribution

The paper provides a comprehensive overview of in vitro and in vivo click chemistry strategies for constructing targeted cancer drug delivery systems.

## Key findings

- Click chemistry enables precise modification of drug delivery systems for improved targeting and controlled release.
- Strategies like CuAAC, SPAAC, and IEDDA are highlighted for their roles in constructing multifunctional drug delivery systems.
- Challenges include the need for better control and integration with emerging technologies to enhance therapeutic outcomes.

## Abstract

Drug delivery systems (DDSs) play a crucial role in improving the efficacy and reducing the side effects of cancer treatment. However, traditional DDSs face challenges such as poor targeting, tissue penetration, and uncontrolled drug release. Click chemistry offers a powerful tool for addressing these limitations by enabling precise modification and targeting of DDSs. This review explores the application of click chemistry in the construction of active targeted DDSs for cancer therapy, focusing on two key strategies: in vitro and in vivo. In vitro strategies involve direct coupling of targeting agents to carrier materials, while in vivo strategies utilize metabolic engineering and click chemistry for cell labeling and drug delivery. The review discusses the advantages and limitations of different click chemistry reactions, including copper-catalyzed azide-alkyne cycloaddition (CuAAC), strain-promoted azide-alkyne cycloaddition (SPAAC), inverse electron-demand Diels-Alder (IEDDA) reaction, thiol-ene reaction, sulfur (VI) fluoride exchange (SuFEx) reaction, and selenium-nitrogen exchange (SeNEx) reaction. It also highlights recent advancements in using click chemistry to construct multifunctional DDSs, such as tumor-targeted biomimetic systems and cell-based delivery systems. Finally, the review outlines the challenges and future directions of click chemistry in drug delivery, emphasizing the need for precise control, expanded toolkits, and integration with emerging technologies to create intelligent, multifunctional DDSs with enhanced therapeutic efficacy and reduced side effects.

Image 1

## Linked entities

- **Chemicals:** thiol-ene (PubChem CID 136880)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, Gypa (glycophorin A) [NCBI Gene 14934] {aka CD235a, GPA}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, BRD4 (bromodomain containing 4) [NCBI Gene 23476] {aka CAP, CDLS6, FSHRG4, HUNK1, HUNKI, MCAP}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Nr1i3 (nuclear receptor subfamily 1, group I, member 3) [NCBI Gene 12355] {aka CAR, CAR-beta, Care2, ESTM32, MB67}, ITGAM (integrin subunit alpha M) [NCBI Gene 3684] {aka CD11B, CR3A, HNA-4, MAC-1, MAC1A, MO1A}, CD47 (CD47 molecule) [NCBI Gene 961] {aka IAP, MER6, OA3}, Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 20848] {aka 1110034C02Rik, Aprf}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, Cd28 (CD28 antigen) [NCBI Gene 12487], Jak2 (Janus kinase 2) [NCBI Gene 16452] {aka Fd17}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, ALK (ALK receptor tyrosine kinase) [NCBI Gene 238] {aka ALK1, CD246, NBLST3}, Igf1 (insulin-like growth factor 1) [NCBI Gene 16000] {aka C730016P09Rik, Igf-1, Igf-I}, ITGAV (integrin subunit alpha V) [NCBI Gene 3685] {aka CD51, IDNDC, MSK8, VNRA, VTNR}, Cd247 (CD247 antigen) [NCBI Gene 12503] {aka 4930549J05Rik, A430104F18Rik, Cd3, Cd3-eta, Cd3-zeta, Cd3h}, Cd274 (CD274 antigen) [NCBI Gene 60533] {aka A530045L16Rik, B7h1, Pdcd1l1, Pdcd1lg1, Pdl1}, Cd19 (CD19 antigen) [NCBI Gene 12478], Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], Cxcl12 (C-X-C motif chemokine ligand 12) [NCBI Gene 20315] {aka Pbsf, Scyb12, Sdf1, Tlsf, Tpar1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}
- **Diseases:** phototoxicity (MESH:D017484), hypoxic (MESH:D002534), ischemia (MESH:D007511), mitochondrial damage (MESH:D028361), SeNEx (MESH:D007222), MOF (MESH:D013651), melanoma (MESH:D008545), inflammatory (MESH:D007249), central nervous system injuries (MESH:D002493), hepatorenal toxicity (MESH:D006530), lung swelling (MESH:D008171), cerebral ischemia (MESH:D002545), Tumor (MESH:D009369), lung cancer (MESH:D008175), CAR-T (MESH:D056733), ovarian cancer (MESH:D010051), liver and kidney damage (MESH:D056486), CuAAC (MESH:C535468), breast cancer (MESH:D001943), bacterial infection (MESH:D001424), solid (MESH:D018250), colorectal cancer (MESH:D015179), intracerebral hemorrhage (MESH:D002543), blood toxicity (MESH:D006402), lung metastasis (MESH:D009362), DDSs (MESH:D000014), DART (MESH:D009105), IEDDA (MESH:D007446), Cytotoxicity (MESH:D064420), weight loss (MESH:D015431), cerebral infarct (MESH:D002544), infection (MESH:D007239)
- **Chemicals:** fluoride (MESH:D005459), alkene (MESH:D000475), Ebselen (MESH:C042986), C6 (MESH:C117224), peptide (MESH:D010455), Fe (MESH:D007501), hydrazone (MESH:D006835), DBU (MESH:C031033), fluorine (MESH:D005461), palladium (MESH:D010165), water (MESH:D014867), phospholipid (MESH:D010743), COS (MESH:C010063), 13C (MESH:C000615229), UiO-66 (MESH:C000711576), HA (MESH:D006820), aminobenzene (MESH:C023650), thiocarbamates (MESH:D013859), barium titanate (MESH:C024547), cholesterol (MESH:D002784), propargyl alcohol (MESH:C028255), Copper (MESH:D003300), benzil (MESH:C006697), NB (MESH:D009556), Silver (MESH:D012834), resveratrol (MESH:D000077185), thioether (MESH:D013440), oxygen (MESH:D010100), sodium alginate (MESH:D000464), bimane (MESH:C021149), ARV771 (MESH:C000720760), poly(divinylbenzene) (MESH:C056745), cRGDfC (MESH:C583418), sugars (MESH:D000073893), chondroitin sulfate (MESH:D002809), acrylate (MESH:C036658), metal (MESH:D008670), TPP (MESH:C061896), Pt (MESH:D010984), PEGDA (MESH:C437167), C (MESH:D002244), MET (MESH:D008795), polymer (MESH:D011108), SO2F2 (MESH:C048899), sialic acid (MESH:D019158), triethylamine (MESH:C016162), CIP (MESH:D002939), PVA (MESH:C063253), PTX (MESH:D017239), poly(I:C) (MESH:D011070), PEG (MESH:D011092), Nitrogen (MESH:D009584), IRT (MESH:D000077146), azide (MESH:D001386), glycan (MESH:D011134), CO (MESH:D002248), lactic acid (MESH:D019344), MOF (MESH:D000073396), L1 (MESH:D000077543), malononitrile (MESH:C000945)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Caenorhabditis elegans (species) [taxon 6239], Fusobacterium nucleatum (species) [taxon 851], Danio rerio (leopard danio, species) [taxon 7955], Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280]
- **Cell lines:** B16-F10 — Mus musculus (Mouse), Mouse melanoma, Cancer cell line (CVCL_0159), H1299 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_0060), CT26 — Mus musculus (Mouse), Mouse colon adenocarcinoma, Cancer cell line (CVCL_7254), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), SPCA1 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_6955), H3122 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_5160), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), MCF-7/ADR — Homo sapiens (Human), High grade ovarian serous adenocarcinoma, Cancer cell line (CVCL_1452), UiO-66 — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_9722), SKOV-3 — Homo sapiens (Human), Ovarian serous cystadenocarcinoma, Cancer cell line (CVCL_0532), LIM1899 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_4435), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), 4T1 — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_0125), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038), U87-MG — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_0022)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12936694/full.md

## Figures

24 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12936694/full.md

## References

219 references — full list in the complete paper: https://tomesphere.com/paper/PMC12936694/full.md

---
Source: https://tomesphere.com/paper/PMC12936694